Abstracts tagged "Bone and sarcoidosis"

Abstract Number: 2259 • 2018 ACR/ARHP Annual Meeting
BONE Sarcoidosis: A French Case Control Study
Imen Ben hassine¹, Christopher Rein², Cloé Comarmond³, Catherine Chapelon-Abric⁴, Nathalie Saidenberg⁵, Benoit Meunier⁶, Nicolas Schleinitz⁷, Noémie Chanson⁸, Marc Scherlinger⁹, Christophe Richez¹⁰, Sandrine Hirschi¹¹, Matthieu Groh¹², Hervé Devilliers¹³, David Saadoun¹⁴, Laurent Arnaud¹⁵ and Patrice Cacoub¹⁶, ¹Internal Medicine and Clinical Immunology, Pitié-Salpêtrière Hospital, Paris, France, ²Rheumatology, UPMC GRC08, Paris 06 University, Pitié Salpétrière Hospital, Paris, France, ³DHU 2iB Internal Medicine Referal Center for Autoimmune diseases Pitie Hospital, Paris, France, ⁴AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, F-75013, Paris, France, Paris, France, ⁵Rheumatology, CHU Avicennes, Bobigny, France, ⁶Internal Medicine, CHU La Timone, Marseille, France, ⁷La Timone University Hospital, Marseille, France, ⁸Internal Medicine, Hopital Bicetre, LE KREMLIN BICETRE, France, ⁹Rheumatology, UMR CNRS 5164 - Immunoconcept, France, Bordeaux, France, ¹⁰UMR CNRS 5164 - Immunoconcept, Bordeaux, France, ¹¹Pneumology, CHU de Strasbourg, Strasbourg, France, ¹²Internal Medicine, Foch, Suresnes, France, ¹³Service de Médecine Interne et Maladies Systémiques, CHU de Dijon, Dijon, France, ¹⁴Sorbonne Universités, UPMC Univ Paris 06, UMR 7211, and Inflammation-Immunopathology-Biotherapy Department (DHU i2B), F-75005, Paris, France; INSERM, UMR_S 959, F-75013, Paris, France; CNRS, FRE3632, F-75005, Paris, France; AP-HP, Groupe Hospitalier Pitié, Paris, France, ¹⁵Department of Medicine, Rheumatology Unit, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden, ¹⁶Department of Internal Medicine and Clinical Immunology, Groupe Hospitalier Pitié-Salpêtrière, Paris, France
Background/Purpose: Osseous manifestations of sarcoidosis are uncommon. We aimed to characterize clinical presentation, distribution of lesions, treatment, and outcomes of bone sarcoidosis. Methods: A French…
Abstract Number: 1183 • 2017 ACR/ARHP Annual Meeting
Bone Sarcoidosis: A Multicenter Study
Camille Glanowski¹, Raphaele Mestiri², Lisa Bialé³, Thierry Carmoi⁴, Gaëlle Leroux⁵, David Saadoun⁶, Catherine Chapelon-Abric⁷ and Patrice Cacoub⁸, ¹Internal Medicine, Hôpital d'instruction des armées de Bégin, Bégin, France, ²Hôpital d'instruction des armées du Val-de-Grâce, Paris, France, ³Hôpital d'instruction des armées de Bégin, Bégin, France, ⁴Service de Médecine Interne, Hôpital d'instruction des armées du Val-de-Grâce, Paris, France, ⁵Internal Medicine, Pitié-Salpêtrière University Hospital, Paris, France, ⁶Sorbonne Universités, UPMC Univ Paris 06, UMR 7211, and Inflammation-Immunopathology-Biotherapy Department (DHU i2B), F-75005, Paris, France; INSERM, UMR_S 959, F-75013, Paris, France; CNRS, FRE3632, F-75005, Paris, France; AP-HP, Groupe Hospitalier, Paris, France, ⁷AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, F-75013, Paris, France, Paris, France, ⁸Department of Internal Medicine and Clinical Immunology, Groupe Hospitalier Pitié-Salpêtrière, Paris, France
Background/Purpose: Studies on bone involvement of sarcoidosis (BS) are scarse. To analyze in depth main features, treatments and follow up of patients presenting a BS.…
Abstract Number: 2011 • 2013 ACR/ARHP Annual Meeting
Osseous Sarcoidosis: Clinical Presentation, Treatment, and Outcomes. Experience From a Large Tertiary Care Academic Hospital
Jeffrey A. Sparks¹, Jakob I. McSparron², Christopher H. Fanta² and Jonathan S. Coblyn³, ¹Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, ²Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA, ³Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA
Background/Purpose: Sarcoidosis is a systemic inflammatory disease characterized by the formation of non-caseating granulomas. Osseous involvement in sarcoidosis is a rare manifestation and has infrequently…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].